Boehringer Partners with KingMiao to Accelerate Innovation of Animal Vaccines Go back »

2025-04-10 | All chapters

Boehringer Ingelheim, a global leader in animal health, has entered into a strategic partnership with Guangzhou KingMiao Animal Health Co., Ltd. , accessing KingMiao’s multivalent vector vaccine technology for the protection of animals against a variety of diseases. Through the company’s first “In China, For Global” R&D partnership in the field of animal health, Boehringer Ingelheim aims to accelerate the innovation process in animal vaccine development. In the future, Boehringer Ingelheim leverages its worldwide R&D network to work with KingMiao in optimizing vaccine seed construction processes, shortening development cycles, and advancing innovative vaccine products.

Source: Boehringer Ingelheim